Antonella Delmestri
PhD
Lead Health Data Scientist
- Alan Turing Alumnus
- EMA-led DARWIN EU® initiative PI data partner
- EHDEN UK data science technical lead
- OHDSI OMOP common data model specialist
- CPRD fob holder for NDORMS
I lead a Data Science group, responsible for the modelling and standardisation of real-world data (RWD) routinely collected by GPs, hospitals and registries, and used in observational research to produce clinical evidence. I am a collaborator of EMA-led DARWIN® EU initiative, EHDEN, OHDSI, and an expert in the OMOP common data model. I am an Alan Turing Alumnus and I serve as member of the Turing Research Ethics (TREx) panel.
My research is focussed on:
- assessment, evaluation and curation of RWD
- impact of RWD quality on medical research output
- data modelling and data standardisation of RWD
- measures of similarity/distance between RWD and their standardised versions
- measurement and enhancement of algorithmic complexity in the context of RWD engineering
- research ethics, research quality, reproducibility, consistency and transparency
BIOGRAPHY
I graduated in Computer Science at the University of Udine and completed my PhD in Information and Communication Technologies at the University of Trento (Italy). I have worked for several years for companies developing firmware and software for electronic devices.
In 2006 I moved to the U.K. to join the Clinical Trial Service Unit (CTSU) at Oxford University. In 2013 I joined NDORMS to work in observational research. In 2018 I joined the European Health Data and Evidence Network (EHDEN) collaboration and in 2019 I started leading the OHDSI UK Data Science technical activities. Between 2021-24 I was a Fellow at the Alan Turing Institute. Since 2022 I am a PI Data Partner in the EMA-led DARWIN® EU initiative.
Recent publications
Comorbidities, medication use, and overall survival in eight cancers: a multinational cohort study of 1.7 million patients across Europe.
Journal article
López-Sánchez I. et al, (2026), Lancet Reg Health Eur, 63
Validating primary and secondary healthcare resource use and costs estimates in OMOP-mapped vs source CPRD-HES data in the UK
Conference paper
Fabiano G. et al, (2026), Value in Health
Characteristics, treatment and survival of patients with chondrosarcoma in five European countries: a DARWIN EU® cohort study.
Journal article
Barchuk A. et al, (2026), Acta Oncol, 65, 193 - 200
Implementation of OMOP and ConcePTION Common Data Models in CPRD GOLD: Risk of Bleeding and Cardiovascular Outcomes From Anticoagulant Use.
Journal article
Hunt NB. et al, (2026), Clin Pharmacol Ther
Data Resource Profile: Prostate cancer data from Clinical Practice Research Datalink linked hospital records, mortality data and cancer registry standardized to the Observational Medical Outcomes Partnership common data model (CPRD-PCa-OMOP).
Journal article
Tan EH. et al, (2026), Int J Epidemiol, 55
Incidence and survival of head and neck cancers in the United Kingdom 2000-2021.
Journal article
Miquel-Dominguez A. et al, (2026), Cancer Epidemiol, 101
Trends in use of Attention-Deficit Hyperactivity Disorder medications among children and adults in five European countries, 2010 to 2023: a population-based observational study.
Journal article
Li X. et al, (2026), Lancet Reg Health Eur, 61
Incidence of first and subsequent fractures in multiple myeloma patients: a parallel cohort study using UK CPRD dataset.
Journal article
Vijjhalwar R. et al, (2026), Osteoporos Int